Drug Interaction Report

Omeprazole and Letermovir: Interaction Details

AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature

Letermovir

Prevymis
+

Omeprazole

Gastrobim Prilosec Prilosec® Prilosec® OTC Primeguard Talicia (as a combination product containing Amoxicillin, Omeprazole, Rifabutin) UlcerGard
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by
Updated Jul 2, 2026
LinkedIn
Interaction severity
Major
Potentially serious — often needs a change or close monitoring.
How we grade severity & evidence

Severity levels

  • Contraindicated: These should generally not be used together.
  • Major: Potentially serious — often needs a change or close monitoring.
  • Moderate: Can be significant — usually manageable with monitoring.
  • Minor: Usually limited clinical impact.

Evidence grades

  • Established: Well documented — supported by controlled studies or strong clinical data.
  • Probable: Good supporting evidence, though not definitively proven.
  • Suspected: Some evidence suggests this interaction, but it is not well established.
  • Possible: Limited or conflicting evidence; the interaction may occur.
  • Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Of 142 documented Omeprazole interactions, 114 are rated major — including this one.
Worried about symptoms right now? Contact your pharmacist or prescriber, or call Poison Control at 1-800-222-1222 (US). Call 911 for an emergency.
At a glance + Theoretical Effects may be stronger
The Bottom Line
Letermovir may raise omeprazole levels by slowing its breakdown, so your care team may watch you more closely and adjust your omeprazole dose if needed. Keep taking both as prescribed and report any new side effects.

Here is what is going on. Letermovir (Prevymis) can slow down one of the liver enzymes that helps break down omeprazole (Prilosec). When that enzyme is slowed, more omeprazole may build up in your body, which could make its effects and side effects a bit stronger.

I want to be honest with you: this is based on lab reasoning and a study with a different drug, not direct proof with omeprazole itself, so it is more of a caution than a certainty. The good news is your care team can handle this easily by watching how you feel and adjusting your dose if needed. Please do not stop either medicine on your own. Just check in with your pharmacist or doctor.

Mechanism: Letermovir is a moderate CYP3A inhibitor. Omeprazole is a CYP3A substrate (primarily CYP2C19, secondarily CYP3A4), so inhibition may increase omeprazole exposure. Neither drug is a prodrug here.

  • Direction: Likely increased omeprazole AUC/Cmax.
  • Magnitude: Not quantified for omeprazole. Surrogate midazolam data showed AUC increases of roughly 47% (IV) and 125% (oral) with letermovir 240 mg PO daily.
  • Onset: Unspecified.
  • Evidence: Theoretical (extrapolated from a probe substrate).

Management: Monitor clinically; omeprazole dose may need individualized adjustment.

Onset
unspecified
Evidence
theoretical
Severity
Major

What happens

Altered omeprazole exposure

Interaction Deep Dive

Taking letermovir together with omeprazole (a CYP3A substrate) can change how much omeprazole is present in the body. During a drug interaction study, giving letermovir (240 mg orally once daily) alongside the CYP3A substrate midazolam (a single 1 mg IV dose) produced rises in midazolam AUC, Cmax and C24hr of 47%, 5% and 174%, respectively. Furthermore, administering letermovir (240 mg orally once daily) with midazolam (a single 2 mg oral dose) raised midazolam AUC and Cmax by 125% and 72%, respectively. Clinical monitoring is advised, and adjusting the dose may be required1.

Why it happens (mechanism)

Inhibition of CYP3A-mediated metabolism of omeprazole; unknown

How to manage this interaction

What your care team may do:

  • Keep an eye on how you respond, since omeprazole levels may run a little higher.
  • Adjust and individualize your omeprazole dose if that becomes appropriate.
  • Monitor you more closely while you are on both medicines.

What you can do:

  • Keep taking both medicines exactly as prescribed.
  • Tell your pharmacist or prescriber about any new or stronger side effects.
  • Do not start, stop, or change either medicine on your own.

Management is individual — confirm any change with your pharmacist or prescriber.

Literature reports

1 report — tap to read

a) In a study evaluating drug interactions, giving letermovir (240 mg orally once daily) together with the CYP3A substrate midazolam (a single 1 mg IV dose) raised midazolam's AUC, Cmax, and C24hr by 47%, 5%, and 174%, respectively. In addition, administering letermovir (240 mg orally once daily) alongside midazolam (a single 2 mg oral dose) increased midazolam's AUC and Cmax by 125% and 72%, respectively 1.

Common questions

Can I take Omeprazole and Letermovir together?

Letermovir may raise omeprazole levels by slowing its breakdown, so your care team may watch you more closely and adjust your omeprazole dose if needed. Keep taking both as prescribed and report any new side effects. Always confirm with your pharmacist or prescriber before making any change.

How serious is the Omeprazole and Letermovir interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How is the Omeprazole and Letermovir interaction managed?

What your care team may do: Keep an eye on how you respond, since omeprazole levels may run a little higher. Adjust and individualize your omeprazole dose if that becomes appropriate. Monitor you more closely while you are on both medicines. What you can do: Keep taking both medicines exactly as prescribed. Tell your pharmacist or prescriber about any new or stronger side effects. Do not start, st… Management is individual — always follow your own care team's guidance.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.

From our Q&A

Real reader questions about these medications, each personally answered by our pharmacist:

Questions for your pharmacist

  • Does my dose of Omeprazole or Letermovir need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there a safer alternative to one of these medications for me?

References (1)

  1. Product Information: PREVYMIS(R) oral tablets, oral pellets, intravenous injection, letermovir oral tablets, oral pellets, intravenous injection. Merck Sharp & Dohme Corp (per FDA), Rahway, NJ, 2024. DailyMed
Was this write-up helpful?
Beyond drug–drug

These medications also interact with supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

major · moderate · minor — check everything you take with our drug–supplement interaction checker.

Check another combination

Our instant two-drug interaction checker is almost here.

Coming soon

The instant two-drug checker is on its way.

In the meantime, browse the directory below to look up any drug and see its documented interactions.

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.